Click to consult the document (french)
Evolucare moves up in software publisher rankings: recognition of its commitment and innovation
We are pleased to announce that Evolucare has climbed to 53ᵉ place this year in the Top 250 French software publishers, published by EY and Numeum, up from 61ᵉ place in 2023.
This progression reflects our ongoing commitment to providing innovative digital solutions that transform the healthcare system.
The top 250 in a nutshell…
👉 In 2023, despite a difficult economic context, French software publishers have maintained growth of +7.6%, albeit more moderate than in 2022 (+10.6%). However, the slowdown affected the entire sector, including the Top 3 (Dassault Systèmes, Ubisoft, Criteo). The number of pure player employees has risen by 4%, compared with 7% in 2022.
Outlook for 2024
- Recruitment: 72% of publishers plan to recruit (compared with 76% in 2023).
- External growth: 54% are planning acquisitions, particularly abroad (53% of cases), taking advantage of falling valuations.
- SaaS sales: The SaaS model accounts for 61% of sales, an increase of 4 percentage points.
- Profitability: 82% of publishers remain profitable, a stable indicator.
- Fundraising: Low, with priority given to non-dilutive financing, supported by solid cash flow.
Strategic and technological priorities
- Artificial intelligence: a priority for 22% of software publishers (compared with 14% in 2023), with 42% having integrated generative AI functionalities.
- Other priorities: Cloud and cybersecurity remain major priorities.
- CSR: 82% of publishers have a structured approach (compared with 75% in 2023).
International
International sales account for 56% of total sales, driven by major publishers and new players investing heavily abroad.
Click to enlarge
EY and Numeum ranking methodology
As a reminder, this ranking is based on a survey of French publishers conducted between May and September 2024. It includes data declared by the companies, supplemented by public information. The companies evaluated are exclusively French, not subsidiaries of foreign groups, and their sales are rounded to the nearest hundred thousand euros.